You are here

Article Text

Article menu
Download PDFPDF
DTB select
More advice on the use of ibuprofen for COVID-19

Abstract

Overview of: Commission of Human Medicines. Commission on Human Medicines advice on ibuprofen and coronavirus (COVID-19). CEM/CMO/2020/017.

  • Health Care Quality, Access, and Evaluation
  • Evidence-Based Medicine

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

https://doi.org/10.1136/dtb.2020.000032

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Overview of Commission of Human Medicines. Commission on Human Medicines advice on ibuprofen and coronavirus (COVID-19). CEM/CMO/2020/017.

    • Contributors DTB Team.

    • Provenance and peer review Commissioned; internally peer reviewed.